Journal ArticleOPEN ACCESS

Fulminant acanthamoeba castellanii encephalitis in an ibrutinib-treated patient

Open Forum Infectious Diseases (2020) 7(2)
DOI: 10.1093/ofid/ofaa025
4Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We report a case of fulminant Acanthamoeba castellanii encephalitis in a patient with chronic lymphocytic leukemia treated with ibrutinib. The unusually rapid neurologic decline and fatal outcome observed are probably related to alterations in immunologic function associated with inhibition of Bruton tyrosine kinase.

Author supplied keywords

Cite

CITATION STYLE

APA

Crothers, J. W., Hsu, L., & Marty, F. M. (2020). Fulminant acanthamoeba castellanii encephalitis in an ibrutinib-treated patient. Open Forum Infectious Diseases, 7(2). https://doi.org/10.1093/ofid/ofaa025

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free